BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33767092)

  • 1. Central nervous system infections and antimicrobial resistance: an evolving challenge.
    Nau R; Sörgel F; Eiffert H
    Curr Opin Neurol; 2021 Jun; 34(3):456-467. PubMed ID: 33767092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
    Sullins AK; Abdel-Rahman SM
    Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections.
    Nau R; Seele J; Eiffert H
    Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections.
    Nau R; Seele J; Djukic M; Eiffert H
    Curr Opin Infect Dis; 2018 Feb; 31(1):57-68. PubMed ID: 29293475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic diffusion to central nervous system].
    Cabrera-Maqueda JM; Fuentes Rumí L; Valero López G; Baidez Guerrero AE; García Molina E; Díaz Pérez J; García-Vázquez E
    Rev Esp Quimioter; 2018 Feb; 31(1):1-12. PubMed ID: 29390599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen Analysis of Central Nervous System Infections in a Chinese Teaching Hospital from 2012-2018: A Laboratory-based Retrospective Study.
    Tian L; Zhang Z; Sun ZY
    Curr Med Sci; 2019 Jun; 39(3):449-454. PubMed ID: 31209818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial use in central nervous system infections.
    Ciummo F; Srinivas P; Biedny J
    Curr Opin Infect Dis; 2021 Jun; 34(3):255-263. PubMed ID: 33741793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotics in the treatment of bacterial infections of the central nervous system].
    Doder R; Canak G; Vukadinov J; Turkulov V; Sević S
    Med Pregl; 2010; 63 Suppl 1():22-6. PubMed ID: 21438200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal Antibacterial and Antifungal Therapies.
    Nau R; Blei C; Eiffert H
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antibacterial agents in infections of the central nervous system.
    Thea D; Barza M
    Infect Dis Clin North Am; 1989 Sep; 3(3):553-70. PubMed ID: 2671139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update.
    Mrowczynski OD; Langan ST; Rizk EB
    Clin Neurol Neurosurg; 2018 Jul; 170():140-158. PubMed ID: 29800828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of patients with central nervous system infections, mainly neurosurgical patients: a retrospective study from 2012 to 2019 in a teaching hospital in China.
    Zhang Z; Song Y; Kang J; Duan S; Li Q; Feng F; Duan J
    BMC Infect Dis; 2021 Aug; 21(1):826. PubMed ID: 34404351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients].
    Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal baclofen pump for spasticity: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(7):1-93. PubMed ID: 23074476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].
    Suzuki H; Sugiyama Y
    Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.
    Nau R; Sörgel F; Eiffert H
    Clin Microbiol Rev; 2010 Oct; 23(4):858-83. PubMed ID: 20930076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.
    Compain C; Sacre K; Puéchal X; Klein I; Vital-Durand D; Houeto JL; De Broucker T; Raoult D; Papo T
    Medicine (Baltimore); 2013 Nov; 92(6):324-330. PubMed ID: 24145700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.